FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vanda Salutari

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Lymph Nodes

Co-author Network

Publications

TOP 3
Gabriella Ferrandina; Marco Petrillo; A Pietragalla; Vanda Salutari; C Conte; Rosa I De Vincenzo; Mariagrazia Distefano; M L Scarciglia; Giovanni Scambia
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.
Sandro Pignata; Carmela Pisano; Alberto Ravaioli; Vanda Salutari; Antonella Savarese; Laura Scaltriti; Giovanni Scambia; Paolo Scollo; Roberto Sorio; Stefano Tamberi; Maria Rosaria Valerio; Enrico Aitini; Alba Brandes; Enrico Breda; Pietro Del Medico; Massimo Di Maio; Antonio Febbraro; Gabriella Ferrandina; Antonella Ferro; Luigi Frigerio; Ciro Gallo; Vittorio Gebbia; Stefano Greggi; Francesco Legge; Alessandra Vernaglia Lombardi; Domenica Lorusso; Alessandro Morabito; Pietro Musso; Donato Natale; Francesco Perrone
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial.
Francesco Deodato; Gabriella Macchia; Luca Grimaldi; Gabriella Ferrandina; Domenica Lorusso; Vanda Salutari; SAVINO CILLA; Vincenzo Valentini; Numa Cellini; Angelo Piermattei; Giovanni Scambia; Alessio Giuseppe Morganti
Stereotactic radiotherapy in recurrent gynecological cancer: a case series.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vanda Salutari (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gabriella Ferrandina; Marco Petrillo; A Pietragalla; Vanda Salutari; C Conte; Rosa I De Vincenzo; Mariagrazia Distefano; M L Scarciglia; Giovanni Scambia
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.
Gynecologic oncology 2013;128(3):518-23.
2011: Sandro Pignata; Carmela Pisano; Alberto Ravaioli; Vanda Salutari; Antonella Savarese; Laura Scaltriti; Giovanni Scambia; Paolo Scollo; Roberto Sorio; Stefano Tamberi; Maria Rosaria Valerio; Enrico Aitini; Alba Brandes; Enrico Breda; Pietro Del Medico; Massimo Di Maio; Antonio Febbraro; Gabriella Ferrandina; Antonella Ferro; Luigi Frigerio; Ciro Gallo; Vittorio Gebbia; Stefano Greggi; Francesco Legge; Alessandra Vernaglia Lombardi; Domenica Lorusso; Alessandro Morabito; Pietro Musso; Donato Natale; Francesco Perrone
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(27):3628-35.
2009: Francesco Deodato; Gabriella Macchia; Luca Grimaldi; Gabriella Ferrandina; Domenica Lorusso; Vanda Salutari; SAVINO CILLA; Vincenzo Valentini; Numa Cellini; Angelo Piermattei; Giovanni Scambia; Alessio Giuseppe Morganti
Stereotactic radiotherapy in recurrent gynecological cancer: a case series.
Oncology reports 2009;22(2):415-9.
2008: Antonia Carla Testa; R Mancari; A Di Legge; F Mascilini; Vanda Salutari; Giovanni Scambia; Gabriella Ferrandina
The 'lead vessel': a vascular ultrasound feature of metastasis in the ovaries.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2008;31(2):218-21.
2008: Gabriella Ferrandina; Vanda Salutari; Marco Petrillo; Arnaldo Carbone; Giovanni Scambia
Conservatively treated glassy cell carcinoma of the cervix.
World journal of surgical oncology 2008;6():92.
2007: Gabriella Ferrandina; Giovanni Scambia; Francesco Legge; Marco Petrillo; Vanda Salutari
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B.
Gynecologic oncology 2007;107(1):154-6.
2007: Gabriella Ferrandina; Manuela Ludovisi; Rosa De Vincenzo; Vanda Salutari; Domenica Lorusso; M Colangelo; T Prantera; M R Valerio; Giovanni Scambia
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(8):1348-53.
2006: Gabriella Ferrandina; Francesco Legge; Vanda Salutari; Amelia Paglia; Antonia Testa; Giovanni Scambia
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations.
European journal of cancer (Oxford, England : 1990) 2006;42(14):2296-302.
2006: Gabriella Ferrandina; Franco O Ranelletti; Francesco Legge; Vanda Salutari; Enrica Martinelli; Andrea Fattorossi; Domenica Lorusso; Gian Franco Zannoni; Valerio Gaetano Vellone; Amelia Paglia; Giovanni Scambia
Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 1):2055-60.
2006: Gabriella Ferrandina; Vanda Salutari; Antonia Testa; Gian Franco Zannoni; Marco Petrillo; Giovanni Scambia
Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case report and review of the literature.
BMC cancer 2006;6():169.
2005: Francesco Legge; Gabriella Ferrandina; Vanda Salutari; Giovanni Scambia
Biological characterization of ovarian cancer: prognostic and therapeutic implications.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv95-101.
2004: Gabriella Ferrandina; Gian Franco Zannoni; Franco O Ranelletti; Francesco Legge; Marco Gessi; Vanda Salutari; Valerio Gallotta; Libero Lauriola; Giovanni Scambia
Cyclooxygenase-2 expression in borderline ovarian tumors.
Gynecologic oncology 2004;95(1):46-51.
2004: Antonia Carla Testa; Gabriella Ferrandina; M Distefano; Erika Fruscella; Donata Mansueto; D Basso; Vanda Salutari; Giovanni Scambia
Color Doppler velocimetry and three-dimensional color power angiography of cervical carcinoma.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2004;24(4):445-52.
2004: Gabriella Ferrandina; Franco O Ranelletti; Francesco Legge; Marco Gessi; Vanda Salutari; Mariagrazia Distefano; Libero Lauriola; Gian Franco Zannoni; Enrica Martinelli; Giovanni Scambia
Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3117-23.
2004: Andrea Fattorossi; Alessandra Battaglia; Gabriella Ferrandina; Ferdinando Coronetta; Francesco Legge; Vanda Salutari; Giovanni Scambia
Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma.
Cancer 2004;100(7):1418-28.
2004: Gabriella Ferrandina; Franco O Ranelletti; Vanda Salutari; Marco Gessi; Francesco Legge; Gian Franco Zannoni; Giovanni Scambia; Libero Lauriola
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions.
Gynecologic oncology 2004;92(2):537-44.
2004: Andrea Fattorossi; Alessandra Battaglia; Gabriella Ferrandina; Alexia Buzzonetti; Francesco Legge; Vanda Salutari; Giovanni Scambia
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients.
Gynecologic oncology 2004;92(1):106-15.
2003: Alessandra Battaglia; Gabriella Ferrandina; Alexia Buzzonetti; Paolo Malinconico; Francesco Legge; Vanda Salutari; Giovanni Scambia; Andrea Fattorossi
Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire.
Immunology 2003;110(3):304-12.
2003: Gabriella Ferrandina; Franco O Ranelletti; Libero Lauriola; Gian Franco Zannoni; Francesco Legge; Marco Gessi; Vanda Salutari; Giovanni Scambia
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer.
Oncology reports 2003;10(6):1799-804.
2003: Gabriella Ferrandina; Franco O Ranelletti; Francesco Legge; Libero Lauriola; Vanda Salutari; Marco Gessi; Antonia Carla Testa; Ulrike Werner; Pierluigi Navarra; Giuseppe Tringali; Alessandra Battaglia; Giovanni Scambia
Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4324-31.
2002: Gabriella Ferrandina; Libero Lauriola; Gian Franco Zannoni; Mariagrazia Distefano; Francesco Legge; Vanda Salutari; Marco Gessi; Nicola Maggiano; Giovanni Scambia; Franco O Ranelletti
Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications.
British journal of cancer 2002;87(10):1145-52.